An Open-label, Two-way Cross-over Study to Determine the Effect of Multiple Doses of Valproic Acid on the Pharmacokinetics and Safety of a Single Oral Dose of Estetrol/Drospirenone in Healthy Female Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Dec 2018
Price : $35 *
At a glance
- Drugs Estelledrospirenone/estetrol (Primary) ; Valproic acid
- Indications Pregnancy
- Focus Pharmacokinetics
- Sponsors Estetra S.A.
- 13 Dec 2018 Status changed from recruiting to completed.
- 04 May 2018 New trial record